Science & Enterprise subscription

Follow us on Twitter

  • A clinical trial is planned to test cannabidiol, or CBD, derived from cannabis as a treatment for hallucinations an…
    about 17 hours ago
  • Venture capital investments fell in the third quarter of 2019, both in dollar volumes and number of deals, with dec…
    about 22 hours ago
  • New post on Science and Enterprise: Q3 Venture Investing Falls, Biotech Remains Hot #Science #Business
    about 22 hours ago
  • While a majority of Americans say they trust research findings that are open to public inspection, about the same n…
    about 3 days ago
  • New post on Science and Enterprise: Infographic – Public Down on Industry-Funded Science #Science #Business
    about 3 days ago

Please share Science & Enterprise

FDA Approves 3-D Digital Mammography System

Hologic Inc., a developer of medical diagnostics and imaging products for women’s health care in Bedford, Massachusetts, says it has received an approval letter from the U.S. Food and Drug Administration (FDA) for the Selenia Dimensions three-dimensional digital mammography tomosynthesis system.

The Selenia Dimensions 3-D system is a new method for breast cancer screening and diagnosis. Breast tomosynthesis produces three-dimensional images which are intended to reveal the inner architecture of the breast, without distortions caused by tissue shadowing or density. Earlier mammography systems generate two-dimensional images.

FDA plans to conduct a review and inspection of Hologic’s manufacturing facility, methods, and controls before granting final pre-market approval of the system. The company says the Selenia Dimensions system is already available commercially outside the United States, including countries in Europe, Latin America and Asia. In North America, commercial systems are installed in Canada and Mexico.

*     *     *

Please share Science & Enterprise ...

Comments are closed.